<?xml version="1.0" encoding="utf-8" ?>
<INTERACTIONS>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>279-MAOI-B.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="MAOI-B " code="N04BD0-001" /></DRUG1>
<DRUG2>
<DRUG name="BUPROPION" rxcui="42347">
<ATC code="N06AX12" />
</DRUG>
</DRUG2>
<DESCRIPTION>Risk of hypertensive crises</DESCRIPTION>
<SEVERITY>CONTRAINDICATION</SEVERITY>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>279-MAOI-B.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="MAOI-B " code="N04BD0-001" /></DRUG1>
<DRUG2>
<CLASS name="REVERSIBLE MAOI-A, INCLUDING LINEZOLIDE AND METHYLENE BLUE" code="NO6AG-001" /></DRUG2>
<DESCRIPTION>Risk of rapid elevation of blood pressure, due to loss of selectivity on the monamine oydase, especially in case of consuming food rich in tyramine (cheese, beer,)</DESCRIPTION>
<SEVERITY>CONTRAINDICATION</SEVERITY>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>279-MAOI-B.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="MAOI-B " code="N04BD0-001" /></DRUG1>
<DRUG2>
<CLASS name="SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)" code="N06AB" /></DRUG2>
<DESCRIPTION>Risk of appearance of a serotonin syndrome</DESCRIPTION>
<SEVERITY>Take into account</SEVERITY>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>279-MAOI-B.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="MAOI-B " code="N04BD0-001" /></DRUG1>
<DRUG2>
<DRUG name="LEVODOPA" rxcui="6375">
<ATC code="N04BA01" />
<ATC code="N04BA02" />
<ATC code="N04BA03" />
</DRUG>
</DRUG2>
<DESCRIPTION>Increased risk of orthostatic hypotension</DESCRIPTION>
<SEVERITY>Take into account</SEVERITY>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>279-MAOI-B.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="MAOI-B " code="N04BD0-001" /></DRUG1>
<DRUG2>
<DRUG name="PETHIDINE " rxcui="6754">
<ATC code="N02AB02" />
<ATC code="N02AG03" />
</DRUG>
</DRUG2>
<DESCRIPTION>Symptoms of central nervous system excitability, evoking a serotonin syndrome: diarrhea, tachycardia, sweats, trembling, confusion, even coma</DESCRIPTION>
<SEVERITY>CONTRAINDICATION</SEVERITY>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>279-MAOI-B.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="MAOI-B " code="N04BD0-001" /></DRUG1>
<DRUG2>
<DRUG name="TRAMADOL" rxcui="10689">
<ATC code="N02AX02" />
</DRUG>
</DRUG2>
<DESCRIPTION>Risk of appearance of a serotonin syndrome</DESCRIPTION>
<SEVERITY>Take into account</SEVERITY>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>279-MAOI-B.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="MAOI-B " code="N04BD0-001" /></DRUG1>
<DRUG2>
<CLASS name="TRIPTANS METABOLIZED BY THE MAO" code="N02CC-002" /></DRUG2>
<DESCRIPTION>Risk of arterial hypertension, of constriction of the coronary arteries</DESCRIPTION>
<SEVERITY>CONTRAINDICATION</SEVERITY>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>279-MAOI-B.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="MAOI-B " code="N04BD0-001" /></DRUG1>
<DRUG2>
<CLASS name="TRIPTANS NOT METABOLIZED BY THE MAO" code="NO2CC-003" /></DRUG2>
<DESCRIPTION>Risk of arterial hypertension, of constriction of the coronary arteries</DESCRIPTION>
<SEVERITY>Not recommended</SEVERITY>
</INTERACTION>
</INTERACTIONS>
